期刊文献+

青蒿琥酯抑制人食管癌Eca-109细胞系的CDC25A表达 被引量:3

Artesunate inhibits the expression of CDC25A in human esophageal carcinoma Eca-109 cell line
下载PDF
导出
摘要 目的观察青蒿琥酯(artesunate,Art)对人食管癌Eca-109细胞系的抑瘤作用,并进一步探讨Art诱导肿瘤细胞周期阻滞与CDC25A、TGF-β表达的关系。方法体外培养人食管癌Eca-109细胞系及正常人外周血单个核细胞(hPBMC),利用MTT法测定细胞增殖;采用流式细胞术(FCM)测定细胞周期;应用RT-PCR方法检测CDC25AmRNA表达,应用Western blot方法检测蛋白表达。结果Art能显著抑制Eca-109细胞的增殖,IC50为(68.80±0.76)μmol/L,而对hPBMC的增殖则没有明显抑制作用。低浓度Art可将细胞阻滞于G0/G1期,S期细胞显著减少,当浓度达到100μmol/L时,细胞阻滞于G2/M期。Art可显著抑制Eca-109细胞CDC25AmRNA及蛋白表达,同时显著上调TGF-β的蛋白表达水平。结论Art可抑制肿瘤细胞生长,上调TGF-β表达,抑制CDC25A表达。 Objective To observe the effects of Art on the proliferation of human esophageal carcinoma Eca-109 cell line and to explore the relationship between cell cycle arrest effect of Art and the expression of CDC25A and TGF-β. Methods Human esophageal carcinoma Eca-109 cells and healthy human peripheral blood mononuclear cells (hPBMCs) were cultured. The inhibitory effects of Art on cell proliferation were determined by MTT method. The changes of cell cycle of tumor cells were assayed by flow cytometry (FCM). The expression of CDC25A mRNA was examined by RT-PCR and the protein expression of CDC25A as well as TGF-β were determined by Western blot. Results Art could significantly inhibit the proliferation of Eca-109 cells. Its IC50 was (68.80 ± 0. 76 ) μmol/L. It had weaker effect on the proliferation of hPBMC. The cell cycle of Eca-109 was greatly changed after the administration of Art. The number of Eca-109 cells in G0/G1 was increased and that of cells among S phase was reduced with lower doses of Art. However, most of cells were arrested in G2/M phase at the concentration of 100 μmol/L. Art could dramatically inhibit the expression of CDC25A in both mRNA and protein levels. The expression of TGF-β was increased at the same concentration of art. Conclusion Art inhibites the proliferation of tumor cells and modulates cell cycle by down regulation of CDC25A and increasing TGF-β.
出处 《基础医学与临床》 CSCD 北大核心 2007年第2期161-165,共5页 Basic and Clinical Medicine
基金 河北省普通高等学校强势特色学科肿瘤学建设课题
关键词 青蒿琥酯 肿瘤 细胞周期 CDC25A TGF-Β artesunate tumor cell cycle C DC25A TGF-β
  • 相关文献

参考文献9

  • 1曹培国,王肇炎.青蒿素及其衍生物的抗肿瘤作用[J].肿瘤防治杂志,2004,11(6):666-668. 被引量:15
  • 2林芳,钱之玉,薛红卫,丁健,林莉萍.青蒿素和青蒿琥酯对人乳腺癌MCF-7细胞的体外抑制作用比较研究[J].中草药,2003,34(4):347-349. 被引量:40
  • 3Galaktionov K,Lee AK,Eckstein J,et al.CDC25 phosphatases as potential human oncogenes[J].Science,1995,269 (5230):1575-1577. 被引量:1
  • 4Pu L,Amoscato AA,Bier ME,et al.Dual G1 and G2 phase inhibition by a novel,selective CDC25 inhibitor 7-chloro-6-(2-morpholin-4 -ylethylamino) -quinoline-5,8 -dione[J].J Biol Chem,2002,277 (49):46877-46885. 被引量:1
  • 5Efferth T,Sauerbrey A,Olbrich A,et al.Molecular modes of action of artesunate in tumor cell lines[J].Mol Pharmacol,2003,64(2):382 -394. 被引量:1
  • 6Nishioka K,Doki Y,Shiozaki H,et al.Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus[J].Br J Cancer,2001,85(3):412 -421. 被引量:1
  • 7Xiao Z,Chen Z,Gunasekera AH,et al.Chk1 mediates S and G2 arrests through CDC25A degradation in response to DNA-damaging agents[J].J Biol Chem,2003,278 (24):21767-21773. 被引量:1
  • 8Barre B,Vigneron A,Coqueret O.The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the CDC25A promoter[J].J Biol Chem,2005,280(16):15673-15681. 被引量:1
  • 9Ray D,Terao Y,Nimbalkar D,et al.Transforming growth factor beta facilitates beta-TrCP-mediated degradation of CDC25A in a Smad3-dependent manner[J].Mol Cell Biol,2005,25 (8):3338-3347. 被引量:1

二级参考文献15

  • 1杨小平,潘启超,梁永钜,张以琳.青蒿酯钠的抗肿瘤作用[J].癌症,1997,16(3):186-187. 被引量:57
  • 2Lai H, Singh N P. Selective cancer cellcytotoxicity from exposure to dihydroartemisinin andholotransferrin [J]. Cancer Lett,1995,91(4) :41-46. 被引量:1
  • 3Singh N P,Lai H. dihydroartemisinin and holotransferrin[J]. Li feSciences, 2001,70: 49 - 56. 被引量:1
  • 4Efferth T,Dunstan H,Sauerbrey A,et al. Theanti-malarial arte sunate is also active againstcancer[J]. Int J Oncol,2001,18(4):767-773. 被引量:1
  • 5Moore J C,Lai H,Li J R,et al. Oraladministration of dihydroartemisinin and ferroussulfate retarded implanted fibrosarcoma growth in therat[J]. Cancer Lett, 1995,98(1): 83 - 87. 被引量:1
  • 6Woerdenbag H J,Moskal T A,Pras N,et al. Cytotocicity of artemisinin-related endoperoxides toEhrlich ascites tumor cells[J]. J Nat Prod,1993,56(6) :849-856. 被引量:1
  • 7Beekman A C,Woerdenbag H J, Uden W V,et al. Stability of artemisinin in aqueousenvironments:impact on its cytotoxic action to Ehrlich ascites tumour cells[J]. J Pharm Pharmacol, 1997, 49 (12):1254-1258. 被引量:1
  • 8Lee C H,Hong H,Shin J,et al. NMR studiesonnovel antitumor drug candidates, Deoxoartemisinin andcarboxypropyl deoxoartemisinin[J]. Biochem BiophysRes Commun, 2000,274 (2): 359 -369. 被引量:1
  • 9Li Y,Shan F,Wu J M,et al. Novel antitumorar temisinin derivatives targeting G1 phase of the cell cycle[J]. Bioorg Med Chem Lett,2001,11(1) :5-8. 被引量:1
  • 10Wu J,Shan F,Wu G,et al. Synthesis and cytotoxicity of artemisinin derivatives containing cyanoarylmethyl group[J]. Eur J Med Chem,2001,36(5) :467-479. 被引量:1

共引文献52

同被引文献58

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部